1. Overview
Congo Red staining is a qualitative histological technique primarily used for the detection of amyloid deposits in tissues. Amyloidosis refers to the extracellular deposition of highly ordered fibrils composed of low-molecular-weight protein subunits, many of which normally circulate in plasma. These abnormal protein deposits accumulate in tissues and organs, leading to structural damage and functional impairment. When amyloidosis is clinically suspected, biopsies from organs such as the stomach, duodenum, colon, or abdominal fat are commonly performed. Histologically, amyloid deposits exhibit a characteristic orange-red coloration with Congo Red stain and demonstrate apple-green birefringence when viewed under polarized light, which is considered diagnostic.
2. Principle of the Test
Congo Red staining works on the principle that Congo Red, an anionic dye, binds selectively to amyloid fibrils. The dye forms hydrogen bridge bonds with the carbohydrate components of the amyloid substrate. Due to its affinity for the β-pleated sheet structure of amyloid fibrils, Congo Red deposits along these fibrils. When examined under polarized light, the stained amyloid exhibits a distinct apple-green birefringence, which differentiates amyloid from other tissue components. This dichroic property under polarized light forms the basis for confirming the presence of amyloid.
3. Preparation of Congo Red Stain
The Congo Red staining solution is prepared using the Highman method. A 1% Congo Red powder dye solution is prepared by dissolving 0.5 g of Congo Red dye in 50 mL of distilled water, followed by the addition of 50 mL of 100% ethanol. The solution can be stored at room temperature and must be filtered before use to obtain the working stain. The reagents required for preparation include Congo Red powder, ethanol, and distilled water.
4. Uses and Indications
Congo Red stain is mainly used for the suspicion and confirmation of amyloidosis in tissue sections. It helps detect amyloid fibrils in histological samples. In addition to tissue diagnosis, Congo Red is also used in the evaluation of preeclampsia. The urine Congo Red kit test has shown high positive predictive value and reproducibility for identifying preeclampsia and is used as a bedside test. Thus, Congo Red staining has applications in both histopathology and clinical screening.
5. Sample Collection and Procedure
Tissue samples for Congo Red staining are usually obtained as paraffin blocks prepared from 10% formalin-fixed tissue. Diagnostic evaluation of amyloidosis may involve blood tests, urine tests, and biopsies, but definitive diagnosis relies on a tissue or bone marrow biopsy.
The staining procedure involves bringing tissue sections to water through xylene and ethanol, followed by staining with Congo Red solution for at least five minutes. The sections are then differentiated briefly in alkaline ethanol, washed with water, counterstained with hematoxylin, dehydrated, cleared with xylene, and mounted with a resinous medium. Positive results are indicated by red-colored intermingled protein fibrils in bright field microscopy.
6. Interpretation and Clinical Significance
On light microscopy, amyloid deposits stain pink to salmon red. Under polarized light, apple-green birefringence confirms the presence of amyloid. Deposits are commonly seen in vessel walls, basement membranes, and extracellular tissue. Both Congo Red positivity and birefringence are required for a definitive diagnosis.
Clinically, Congo Red staining is significant because it enables identification and confirmation of amyloid deposition by binding to β-pleated sheet structures. Enhanced techniques such as Texas Red-filtered fluorescence microscopy may improve sensitivity and specificity. The stain also aids in differentiating amyloid from amyloid-like but non-amyloid materials in tissue biopsies.
7. Limitations
Congo Red staining has several limitations. The dye may bind to other tissue components such as keratin, collagen, or elastic fibers, leading to false-positive results. Early stages of amyloidosis may not show sufficient amyloid deposition, resulting in false-negative findings. Interpretation is subjective and requires experience and expertise. The test also requires biopsy specimens, and both false-positive and false-negative results may occur.
